Medtronic's 3 Most Promising Businesses

Updated
Medtronic's 3 Most Promising Businesses

Medtronic's one of the most well-known names in the medical device industry -- and for good reason. For years, this company has delivered for investors as it's ruled the top of the device industry, and its cardiovascular device sales have formed a solid core of sales.

However, the cardiac device industry has been hit with pricing pressures and tough competition lately. Even a company of Medtronic's size hasn't been able to overcome the fallout: The company's cardiac rhythm disease management segment, its largest single business division by sales, saw sales fall 2% in the company's most recent fiscal year.

Medtronic has turned to the future, embracing growing businesses that one day could power this company's success to new heights. What should you be keeping an eye on? In the video below, Fool contributor Dan Carroll shows you three of Medtronic's most promising businesses and how they could help this stock reward investors in the long run.


Medtronic's success and dominance over the years is a great investor's model of just how investing for the long term can unlock your financial freedom. Don't know where to get started? The Motley Fool's special free report "3 Stocks That Will Help You Retire Rich" names specific investment opportunities that could help you build long-term wealth and help you retire well. The Fool also outlines critical wealth-building strategies that every investor should know. Click here to keep reading.

The article Medtronic's 3 Most Promising Businesses originally appeared on Fool.com.

Fool contributor Dan Carroll has no position in any stocks mentioned. The Motley Fool owns shares of Medtronic. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Advertisement